Survey reveals strong public and professional confidence in digital health technologies to drive personalized treatment, surgical precision, and medical training across Europe....
Under Montag’s leadership, the company reports 6.8% revenue growth and a 16.6% EBIT margin, while widening EPS guidance to address rising geopolitical and trade-related risks. ...
Marie® may soon become the first FDA-cleared upright particle therapy solution, aiming to reshape radiotherapy delivery across the U.S....
Marking its first investment in Asia and the cardiovascular gene therapy space, Angelini Ventures backs Singapore-based Nuevocor to drive clinical development of NVC-001 for LMNA DCM....
ESTRO debut highlights breakthrough in collision-free, non-coplanar beam planning through surface-guided technology integration...
With strong U.S. demand, a robust radiopharma rollout, and 4% organic revenue growth, CEO Peter Arduini highlights precision care strategy and innovation as GE HealthCare revises guidance under tariff pressures....
With $5.3B in revenue and $3.35 EPS, BD’s CEO highlights strong margin execution, a $2.5B U.S. investment, and BD Medical’s double-digit growth as the company navigates macro headwinds and tariff risks....
Backed by double-digit gains in robotics and wound care, Smith+Nephew holds steady on full-year guidance despite China headwinds and tariff uncertainty....
New entity, Otsuka ICU Medical LLC, combines global manufacturing scale with U.S. production to enhance supply resiliency and introduce PVC-free innovations....
Special pricing on telehealth services offered during the month of May for millions of individuals and families enrolled in tax-free flexible spending accounts (FSAs) and health savings accounts (HSAs)...